ScoreWhy is Senores Pharmaceuticals Ltd ?
1
With a Operating Losses, the company has a Weak Long Term Fundamental Strength
- Low ability to service debt as the company has a high Debt to EBITDA ratio of 5.66 times
2
Flat results in Dec 24
- NO KEY NEGATIVE TRIGGERS
3
With ROCE of 7.2, it has a Very Expensive valuation with a 5.9 Enterprise value to Capital Employed
Real-Time Research ReportHow much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Drugs)
When to re-enter? - We will constantly monitor the company and review our call based on new data
No Data Found
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
0.00%
EBIT Growth (5y)
0.00%
EBIT to Interest (avg)
3.34
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
1.24
Sales to Capital Employed (avg)
0.17
Tax Ratio
Tax Ratio is Negative%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
24.12%
ROCE (avg)
-0.82%
ROE (avg)
15.40%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
76
Industry P/E
33
Price to Book Value
11.64
EV to EBIT
82.73
EV to EBITDA
62.80
EV to Capital Employed
5.94
EV to Sales
12.18
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
7.18%
ROE (Latest)
15.40%
Loading Valuation Snapshot...
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
RSI
Bollinger Bands
KST
Dow Theory
No Trend
OBV
No Trend
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
